Document Detail


The effectiveness of risperidone in the treatment of three children with feeding disorders.
MedLine Citation:
PMID:  15662156     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Children with histories of extensive medical interventions in early childhood, especially those involving the gastrointestinal tract, are at-risk for residual feeding problems long after the medical issues have resolved. This case series describes the inpatient multidisciplinary treatment of 3 consecutive preadolescent children (ages 9, 8, and 7 years) admitted to our rehabilitation facility. Each child was admitted with a severe feeding disorder and histories of failure-to-thrive (FTT) that had required enteral nutritional interventions. Each child also had comorbid anxiety and mood symptoms. The addition of risperidone to behavioral and psychopharmacologic treatments was observed to significantly increase oral intake and accelerate weight gain. In 2 of 3 patients, assistive feeding interventions were successfully discontinued; and in a 3rd patient, enteral nutritional support was reduced by 74%. These cases suggest that risperidone may be a safe and effective adjunctive treatment, when behavioral feeding therapy is not sufficiently successful for children who have chronic and complicated medical and psychiatric presentations.
Authors:
Paul Berger-Gross; Daniel J Coletti; Karen Hirschkorn; Elise Terranova; Edwin F Simpser
Related Documents :
10773906 - Tamil nadu nutritional survey comparing children aged 0-3 years with the nchs/cdc refer...
943936 - Sahel nutrition survey, 1974.
2929486 - Effects of missing breakfast on the cognitive functions of school children of differing...
19420226 - Description of a standardized nutrition classification plan and its relation to nutriti...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of child and adolescent psychopharmacology     Volume:  14     ISSN:  1044-5463     ISO Abbreviation:  J Child Adolesc Psychopharmacol     Publication Date:  2004  
Date Detail:
Created Date:  2005-01-21     Completed Date:  2005-05-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9105358     Medline TA:  J Child Adolesc Psychopharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  621-7     Citation Subset:  IM    
Affiliation:
Department of Medical Services, St. Mary's Healthcare System for Children, Bayside, New York 11360, USA. pbergwrgross@stmaryskids.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / adverse effects,  therapeutic use*
Anxiety Disorders / complications,  drug therapy
Child
Child Behavior Disorders / complications,  drug therapy
Feeding and Eating Disorders of Childhood / complications,  drug therapy*
Female
Humans
Male
Risperidone / adverse effects,  therapeutic use*
Weight Gain / drug effects
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 106266-06-2/Risperidone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adolescent weight loss during treatment with olanzapine.
Next Document:  Sedation for terminally ill patients with cancer with uncontrollable physical distress.